Edwards Training Village at EACTS 2025
Edwards Training Village: Pioneering Excellence in Cardiac Surgery
Eager to elevate your technique? For additional details and registration support, reach out to your Edwards representatives. Spaces are limited, so act quickly!
Thursday 10 Oct 2024
Lifetime management in light of SAPIEN 3 Ultra RESILIA valve
Explore the newest advancements in transcatheter aortic valve technology and techniques, along with lifetime management strategies.
Friday 11 Oct 2024
Lifetime management in light of SAPIEN 3 Ultra RESILIA valve
Explore the newest advancements in transcatheter aortic valve technology and techniques, along with lifetime management strategies.
†Consult instructions for use for device preparation instructions
*Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
Reference:
1. Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).